(134 days)
Babyleo TN500 is intended for use with premature babies and neonates and can be used as both an incubator and a radiant warmer. When the product is switched between incubator and radiant warmer operation, patients continue to be kept warm during the transition. The device provides a thermally requlated environment for patients with a body weight of up to 5 kg (11 lbs) and a height of up to 55 cm (22 in). The device can be operated as either a closed care unit or an open care unit. As a closed care unit, Babyleo TN500 is an incubator. Neonates are kept warm in the patient compartment with humidifiable air, which can be enriched with oxygen (option). As an open care unit, Babyleo TN500 is a radiant warmer. Babyleo TN500 provides controlled ambient conditions for premature babies and neonates. The following parameters are regulated, according to the intended use: Temperature; Humidity; Oxygen (option).
The device Babyleo TN500 is a medical device used to maintain environmental conditions suitable for preterm babies and neonates. The important features are temperature and humidity. The operational principle is a combination of a neonatal incubator and an open warmer. Babyleo TN500 can be operated in closed care therapy as an incubator according to IEC60601-2-19 or in open care therapy as a warmer according to IEC60601-2-21. Additionally, an optional x-ray translucent heated mattress is intended to provide sensible heat to the preterm babies and neonates. The device consists of the following components: Incubator (=bassinet) with a convection heater and closed humidification system for the patient, trolley, radiant warmer, display, mattress, x-ray tray and height adjustment. Optional components are scale, heated mattress, drawer, oxygen regulation with cylinder holder and Auto Thermo package and Developmental Care package. The subject of this submission is the addition of the optional Touch time function, which can be activated in order to stabilize the thermal environment in the patient compartment when the hand ports are opened. It supports users during routine tasks (e.g. changing diapers, washing the baby, checking sensors). Additionally, the scale resolution is changed from 5q to 10g.
Here's a breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided text:
Device: Babyleo TN500 (Neonatal Incubator and Radiant Warmer)
Reason for Submission: Addition of optional "Touch time" function and change in scale resolution.
Acceptance Criteria and Reported Device Performance
Since this 510(k) submission is for modifications to an already cleared device (K162821), the core performance specifications of the Babyleo TN500 remain unchanged and are considered the acceptance criteria based on the predicate device. The changes are specifically for the "Touch time" feature and the scale resolution.
The table below focuses on the elements changed or directly impacted by the submission. For other parameters, the document states "Identical" meaning the performance meets the existing criteria from the predicate device (K162821).
| Feature | Acceptance Criteria (from K162821) | Reported Device Performance (K182859) |
|---|---|---|
| Touch time Function | N/A (New feature in this submission) | The optional Touch time function can be activated in order to stabilize the thermal environment in the patient compartment when the hand ports are opened. It also increases air circulation and disables audio signals of certain alarms for a maximum of 20 minutes. |
| Scale Resolution | 5 g (OIML) or 1 g (standard version) | 10 g (OIML) or 1 g (1 oz) (Changed from 5g to 10g for OIML) |
| Risk Analysis | Acceptable risks identified and mitigated according to ISO 14971 for the original device. | Risks for the "Touch time" modification were identified and mitigated according to ISO 14971, ensuring risk acceptability criteria have been met. |
| Conformity to Standards | IEC 60601-1; 60601-1-2; 60601-2-19; 60601-2-21 | Testing was performed according to applicable Standards IEC 60601-1-2; 60601-2-19; and 60601-2-21 for the Touch time feature. Verification and validation testing were conducted in conformance to FDA recognized standards. |
Study Information
The provided document describes a verification and validation (V&V) testing approach for the modifications, not a typical clinical study with patient data, ground truth establishment, or human reader involvement. This is common for modifications that do not significantly alter the intended use or fundamental technological characteristics of a device.
-
Sample size used for the test set and the data provenance:
- Test Set Size: Not explicitly stated as individual "samples" in terms of patient data. The testing was focused on the device's functionality and safety regarding the "Touch time" feature and scale resolution. This likely involved engineering bench testing or simulated use cases.
- Data Provenance: Not specified. Given the nature of V&V testing for a medical device modification, it would be laboratory-based data generated during manufacturing and development, likely in Germany (Drägerwerk AG & Co. KGaA is in Luebeck, Germany) with adherence to international standards. It is prospective testing specific to the modifications.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable as this was not a study requiring expert-established ground truth in the clinical sense (e.g., diagnosis). The ground truth for device performance features like temperature regulation, alarm functionality, and scale accuracy is typically against engineering specifications and validated test equipment.
-
Adjudication method for the test set:
- Not applicable. The V&V testing would involve comparing device performance against predetermined engineering specifications and international standards, rather than expert adjudication of clinical outcomes.
-
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. This is not an AI-assisted device and therefore no MRMC study was conducted.
-
If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
- Not applicable. This device is not an algorithm-only device. The V&V testing evaluated the functional performance of the device and its new feature.
-
The type of ground truth used:
- Engineering Specifications and International Standards: The performance of the device and its new features were evaluated against established engineering specifications for the device and compliance with recognized international standards (IEC 60601-1-2, 60601-2-19, and 60601-2-21). This is the "ground truth" for demonstrating safety and effectiveness of device functions.
-
The sample size for the training set:
- Not applicable. This is not a machine learning or AI device that requires a training set.
-
How the ground truth for the training set was established:
- Not applicable for the same reason as above.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA acronym with the agency's name on the right. The symbol on the left is a stylized representation of the Department of Health & Human Services emblem. To the right of the emblem is the acronym "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in large, bold, blue letters, and the word "ADMINISTRATION" in smaller, blue letters below.
February 22, 2019
Drägerwerk AG & Co. KGaA % Gale Winarsky US Agent Draeger Medical Systems, Inc. 3135 Quarry Road Telford, Pennsylvania 18969
Re: K182859
Trade/Device Name: Babyleo TN500 Regulation Number: 21 CFR 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: Class II Product Code: FMZ, FMZ, FMT Dated: January 28, 2019 Received: January 30, 2019
Dear Gale Winarsky:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmp/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Sapana Patel -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control. and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K182859
Device Name Babyleo TN500
Indications for Use (Describe)
Babyleo TN500 is intended for use with premature babies and can be used as both an incubator and a radiant warmer. When the product is switched between incubator warmer operation, patients continue to be kept warm during the transition. The device provides a thermally regulated environment for patients with a body weight of up to 5 kg (11 lbs) and a height of up to 55 cm (22 in). The device can be operated as either a closed care unit or an open care unit. As a closed care unit, Babyleo TN500 is an incubator. Neonates are kept warm in the patient with humidifiable air, which can be enriched with oxygen (option). As an open care unit, Babyleo TN500 is a radiant warmer. Babyleo TN500 provides controlled ambient conditions for premature babies and neonates. The following parameters are regulated, according to the intended use: Temperature; Humidity: Oxygen (option).
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
C)
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is a dark blue color, and the background is white. The two dots above the "a" are also dark blue and are slightly larger than the other letters in the word. The word is the logo for the Dräger company, which is a German company that makes medical and safety technology.
510(k) Summary (K182859)
l. SUBMITTER
Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23558 Luebeck, Germany
Phone: +49 451 882 0 Fax: +49 451 882 3018
Contact Person: Dr. Bettina Möbius Submitter's US contact Person: Gale Winarsky Date prepared: February 14th, 2019
II. DEVICE
Name of Device: Common or Usual Name: Classification Name: Requlatory Class: Product code:
Babyleo TN500 Incubator and Warmer Incubator, neonatal (21 CFR 880.5400) . FMZ, FMT
PREDICATE DEVICE lll.
Babyleo TN500, K162821
DEVICE DESCRIPTION IV.
The device Babyleo TN500 is a medical device used to maintain environmental conditions suitable for preterm babies and neonates. The important features are temperature and humidity. The operational principle is a combination of a neonatal incubator and an open warmer.
Babyleo TN500 can be operated in closed care therapy as an incubator according to IEC60601-2-19 or in open care therapy as a warmer according to IEC60601-2-21. Additionally, an optional x-ray translucent heated mattress is intended to provide sensible heat to the preterm babies and neonates.
The device consists of the following components: Incubator (=bassinet) with a convection heater and closed humidification system for the patient, trolley, radiant warmer, display, mattress, x-ray tray and height adjustment.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue, and the two dots above the "a" are also blue. The background is white. The word is the logo for the Dräger company, which manufactures medical and safety technology products.
Optional components are scale, heated mattress, drawer, oxygen regulation with cylinder holder and Auto Thermo package and Developmental Care package. The subject of this submission is the addition of the optional Touch time function, which can be activated in order to stabilize the thermal environment in the patient compartment when the hand ports are opened. It supports users during routine tasks (e.g. changing diapers, washing the baby, checking sensors). Additionally, the scale resolution is changed from 5q to 10g.
V. INDICATIONS FOR USE
Babyleo TN500 is intended for use with premature babies and neonates and can be used as both an incubator and a radiant warmer. When the product is switched between incubator and radiant warmer operation, patients continue to be kept warm during the transition. The device provides a thermally requlated environment for patients with a body weight of up to 5 kg (11 lbs) and a height of up to 55 cm (22 in). The device can be operated as either a closed care unit or an open care unit. As a closed care unit, Babyleo TN500 is an incubator. Neonates are kept warm in the patient compartment with humidifiable air, which can be enriched with oxygen (option). As an open care unit, Babyleo TN500 is a radiant warmer. Babyleo TN500 provides controlled ambient conditions for premature babies and neonates. The following parameters are regulated, according to the intended use: Temperature; Humidity; Oxygen (option).
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE VI. PREDICATE DEVICE
The primary technological characteristics of the Babyleo TN500 remain unchanged. The medical device is an incubator and an open warmer. The modification adds an optional Touch Time feature, which increases air circulation and disables the audio signals of certain alarms for a maximum of 20 minutes. The change in the scale resolution from 5g to 10g does not affect the functionality of the device.
VII. PERFORMANCE DATA
The performance specifications of Babyleo TN500 remain unchanged. The results of the risk analysis and verification testing performed for the Touch time feature indicate no new issues related to the safety and effectiveness of the modified device. Testing was performed according to applicable Standards IEC 60601-1-2: 60601-2-19; and 60601-2-21.
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. The two dots above the "a" are also blue.
Software Verification and Validation Testing
Verification and validation testing were conducted in conformance to the FDA recognized standards. Performance data only related to the Touch time feature has been tested and evaluated.
Risk Analysis
An analysis of the risk for the modification Touch time for the Babyleo TN500 was carried out according to ISO 14971. Possible risks were identified which result from the modification Touch time. Based on the risk identification, Risk Control Measures for the Touch time feature were defined and Verification and Validation activities were carried out in order to ensure risk acceptability criteria have been met and the risks have been mitigated.
CONCLUSIONS VIII.
The intended use of Babyleo TN500 has not been changed as a result of these modifications. The comparison with the predicate device and the results from a risk analysis and verification testing of the modified Babyleo TN500 demonstrate that it is as safe and effective as the previously cleared predicate in K162821.
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the word "Dräger" in a bold, blue font. The "ä" in Dräger has two dots above it. The logo is simple and clean, with a focus on the company name.
Image /page/6/Picture/2 description: The image shows the word "Dräger" in a stylized, sans-serif font. The word is in blue, and the two dots above the "a" are also blue. The font is bold and the letters are close together.
| Babyleo TN500 | Babyleo TN500Special 510(k) | |
|---|---|---|
| Status | K162821 | |
| Manufacturer | Drägerwerk AG & Co. KGaA | Identical |
| Classification Name / | Incubator, neonatal / Warmer, Infant Radiant | Identical |
| Product code | FMZ/FMT | |
| 510(k) | K162821 | |
| Regulation Number: | 21 CFR 880.5400 | Identical |
| Class: | II | Identical |
| Standards | 60601-1; 60601-1-2;60601-2-19; 60601-2-21 | Identical |
| Indications for use | Babyleo TN500 is intended for use with premature babies and neonates and can be used as both anincubator and a radiant warmer. When the product is switched between incubator and radiant warmeroperation, patients continue to be kept warm during the transition. The device provides a thermallyregulated environment for patients with a body weight of up to 5 kg (11 lbs) and a height of up to 55 cm (22in). The device can be operated as either a closed care unit or an open care unit. As a closed care unit,Babyleo TN500 is an incubator. Neonates are kept warm in the patient compartment with humidifiable air,which can be enriched with oxygen (option). As an open care unit, Babyleo TN500 is a radiant warmer.Babyleo TN500 provides controlled ambient conditions for premature babies and neonates. The followingparameters are regulated, according to the intended use: Temperature; Humidity; Oxygen (option). | Identical |
| Operating noise | ||
| Operating noise volume inpatient compartment | Typically 40 dB(A) (Measured without oxygen application) | Identical |
| Babyleo TN500 | Babyleo TN500 | |
| Special 510(k) | ||
| Alarm Volume | 50 to 70 dB(A) (according to IEC 60601-2-19 and IEC 60601-2-21) | Identical |
| Power failure alarm | Yes (65 dB(A), 10 min) | Identical |
| Principles of operation | ||
| General | Radiant Warmer and Neonatal Incubator | Identical |
| Warmer operation | ||
| Warmer | Radiant Warmer | Identical |
| Maximum Irradiance ofWarmer | 32 mW/cm2 (at 100% power); 18 mW/cm2 (at 60% power) 10 mW/cm2 (at 30% Power) | Identical |
| Incubator operation | ||
| Heater | Convective heater | Identical |
| Warm up time | 15 to 20 min | Identical |
| Humidification principle | Boiling of Aquadest (destilled water) | Identical |
| Flow velocity over mattresssurface | 10 cm/s (3.94 in/s) (at 36°C) | Identical |
| Maximum Carbon Dioxide(CO2) concentration in theincubator measured inaccordance with IEC 60601-2-19 | <0.5 Vol% | Identical |
| Electrical Description | ||
| Babyleo TN500 | Babyleo TN500Special 510(k) | |
| Power supply | 100 V to 240 V, 50/60 Hz | Identical |
| Maximum current / power consumption | 10A / 1000W | Identical |
| Electrical safety | according to IEC 60601-1 | Identical |
| Gas supply (option) | ||
| O2 operating pressure | 270 to 600 kPa | Identical |
| Measured value display | ||
| Radiant Warmer | ||
| Setting range | Off, 10 % to 100 % | Identical |
| Prewarm Mode | Yes | Identical |
| Air temperature regulation | ||
| Measurement regulation | 13 to 45 °C (55.4 to 113 °F) | Identical |
| Measurement uncertainty | $\pm$ 0.8°C (1.44 °F) | Identical |
| Air Mode temperature setting range | 20 to 39 °C (68 to 102.2 °F) in 0.1 ° inc. | Identical |
| Air Mode override | <28 °C (82.4 °F), after confirmation>37 °C (98.6 °F), after confirmation | Identical |
| Babyleo TN500 | Babyleo TN500 | |
| Special 510(k) | ||
| Skin Temperature regulation | ||
| Measurement range | 13 to 43 °C (55.4 to 109.4 °F) | Identical |
| Temperature Sensor for Skin | Thermo Trace (Dräger) | Identical |
| Measurement uncertaintysensors | ± 0.1°C (0.18 °F) | Identical |
| Measurement uncertaintyentire system | ± 0.3°C (0.54 °F) | Identical |
| Skin temperature Modesetting range | 34 to 38 °C (93.2 to 100.4 °F) in 0.1 °C | Identical |
| Skin temperature Modeoverride | >37 °C (98.6 °F), after confirmation | Identical |
| Heated mattress (Option) | ||
| Setting range | Off, 35°C to 39°C, AUTO | Identical |
| Oxygen regulation (Option) | ||
| Measurement range | Normal range: 18 to 65 Vol %Extended range: 66 to 99 Vol% | Identical |
| Measurement uncertainty | ± 2.5 Vol% (+ 2.5 % of measured value) | Identical |
| Setting range | 21 to 65 Vol% (>40 Vol%, after confirmation) | Identical |
| O2 rise time from 21 to65 Vol% | <10 min | Identical |
| Babyleo TN500 | Babyleo TN500 | |
| Special 510(k) | ||
| Oxygen Cylinder Holder | Yes | Identical |
| Humidity System Description | ||
| Measurement range | Normal range: 30 to 99 % r. H.Extended range: 10 to 29 % r. H. | Identical |
| Measurement uncertainty | ±10 % | Identical |
| Setting Range | Off, 30 to 99 % r. H. in steps of 1 %, AUTO | Identical |
| Noise and light measurement(Developmental care packageOption) | Yes | Identical |
| Noise Measurement range | 40 to 90 dB(A) | Identical |
| Light Measurement range | 3 to 999 Lux (1 to 93 fc) | Identical |
| AutoThermo package (Option) | Yes | Identical |
| Data exchange and interfaces | Serial Port (COM, RS232), USB (USB 1.1 or USB 2.0); Service port (RJ45 / LAN) | Identical |
| Physical Description | ||
| Weight (without options andaccessories) | <140 kg | Identical |
| Width & Depth | 690 mm x 1154 mm(27.17 in x 45.43 in) | Identical |
| Height (with hood closed) | 1850 mm to 2250 mm (72.83 in to 88.58 in) | Identical |
| Babyleo TN500 | Babyleo TN500 | |
| Special 510(k) | ||
| (height adjustment range: 400 mm) | ||
| Height of the mattress | 700 to 1100 mm (27.56 in to 43.31 in) | Identical |
| Mattress | 450 mm x 690 mm (17.72 in x 27.17 in) | Identical |
| Material (no implants) | ||
| Material used for indirectpatient contact | Metal (e.g Aluminium) Synthetic material (e.g.TPE) | Identical |
| Material used for directpatient contact | Textile (Vowalon Medilind) | Identical |
| Biocompatibility | according to ISO 10993 | Identical |
| Sterilization | N/A; non sterile | Identical |
| Scale Description | ||
| Range | 200 g to 10 kg | Identical |
| Resolution | 5 g (OIML)) or 1 g (standard version) | 10 g (OIML) or 1 g (1 oz) |
| Integrated X-ray cassette /tray | Yes | Identical |
| Drawer (Option) | Yes | Identical |
| Bed-tilt mechanism(Trendelenburg) | Continuous up to 13° | Identical |
| Babyleo TN500 | Babyleo TN500 | |
| Special 510(k) | ||
| Environmental Description during operation | ||
| Ambient operatingtemperature | 20 to 35 °C (68 to 95°F) | Identical |
| Operating barometric range | 620 to 1100 hPa (9.0 to 16.0 psi) | Identical |
| Humidity operating range | 20 to 95 %, noncondensing | Identical |
| Environmental Descriptionduring storage | Temperature - 20 to 60 °C (to 4 to 140 °F)Ambient pressure 500 to 1100 hPa (7.3 to 16.0 psi)Relative humidity 10 to 95 %, non-condensing | Identical |
| Touch Time Option | N/A | The optional Touch timefunction can beactivated in order tostabilize the thermalenvironment in thepatient compartmentwhen the hand ports areopened. |
{7}------------------------------------------------
Image /page/7/Picture/1 description: The image shows the word "Dräger" in a bold, blue font. The "a" in Dräger has an umlaut, which is two dots above the letter. The logo is simple and modern, and the blue color gives it a sense of trustworthiness.
Image /page/7/Picture/2 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. There are two dots above the letter "a".
{8}------------------------------------------------
Image /page/8/Picture/1 description: The image shows the word "Dräger" in a bold, blue font. The "ä" in Dräger has two dots above it. The logo is simple and clean, with a focus on the company name.
Image /page/8/Picture/2 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. The "ä" in Dräger has two dots above it.
{9}------------------------------------------------
Image /page/9/Picture/1 description: The image shows the word "Dräger" in blue font. The word is written in a bold, sans-serif font. The two dots above the "a" are also blue. The background is white.
Image /page/9/Picture/2 description: The image shows the word "Dräger" in blue font. The font is bold and sans-serif. The two dots above the "a" are also blue.
{10}------------------------------------------------
Image /page/10/Picture/1 description: The image shows the word "Dräger" in a bold, blue font. The "ä" in the word has two dots above it. The word is centered and takes up most of the image.
Image /page/10/Picture/2 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. The two dots above the "a" are also blue.
{11}------------------------------------------------
Image /page/11/Picture/1 description: The image shows the word "Dräger" in a bold, blue font. The "ä" in Dräger is represented by two blue dots above the letter "a". The word is the logo for the Dräger company, which specializes in medical and safety technology.
Image /page/11/Picture/2 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. The two dots above the "a" are also blue and are slightly larger than the other letters.
{12}------------------------------------------------
Image /page/12/Picture/1 description: The image shows the word "Dräger" in blue font. The word is written in a bold, sans-serif font. The two dots above the "a" are also blue. The background is white.
Image /page/12/Picture/2 description: The image shows the word "Dräger" in a bold, sans-serif font. The word is blue. The "ä" in Dräger has two dots above it.
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).